Phase I study of entinostat (Ent), atezolizumab (A), carboplatin (C), and etoposide (E) in previously untreated extensive-stage small cell lung cancer (ES-SCLC), ETCTN 10399 Meeting Abstract
| Authors: | Gentzler, R. D.; Piekarz, R.; Villaruz, L. C.; Rhee, J. C.; Lai, W. C. V.; Horton, B.; Mock, J.; Hanley, M.; Rudek, M. A.; Phelps, M. A.; Carducci, M. A.; Rudin, C. M. |
| Abstract Title: | Phase I study of entinostat (Ent), atezolizumab (A), carboplatin (C), and etoposide (E) in previously untreated extensive-stage small cell lung cancer (ES-SCLC), ETCTN 10399 |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304238 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.e20606 |
| Notes: | Meeting Abstract: e20606-- This meeting was also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
